Profile and conditions

• Your project matches each of the following 4 conditions:

1. It is aimed at advancing a new therapy, diagnosis and/or specific prevention of a particular human disease/medical issue or comparing existing therapies, diagnostics or preventive methods in order to find out their relative efficacy and cost-effectiveness.
2. It is directed at research that is positioned late in the path from discovery to a specific application (i.e. there is a clinically relevant proof of concept) and aims at translating scientific findings into clinical applications rather than creating new knowledge from scratch. On the other hand, it is not positioned too late in the path from discovery to application: it does not consist of implementation activities that no longer require any research.
3. It offers a clear applicability with an added value for the Flemish health situation, including at least a positive medical impact for a particular group of patients or a cost reduction for the Flemish healthcare system.
4. At the time of submitting the application (or in the near future), the industry is not interested in your project for commercial reasons.

• For the execution of the project, you need bench fees, equipment and personnel grants.
• The organisation(s) to which you belong, are research centre(s) that comply with the definition of a ‘research and knowledge-dissemination organisation’ as mentioned in Art. 2, sec. 83 of the European legislation no. 651/2014. When in doubt, please contact the FWO (tbm@fwo.be).
• The project executors are the owners of their own results.
• Per call, a researcher can act as main supervisor-spokesperson for maximum one TBM project and as co-supervisor for maximum two TBM projects, regardless of whether budget is requested or not. The total of requested and ongoing TBM projects on behalf of a single supervisor-spokesperson may not exceed two. The date on which a newly awarded TBM project would normally start, is used as reference date to calculate this total. This means that there can be only a single ongoing research project on the date that your new research project will start. If there are already two ongoing research projects, one must end on the 31st of December of the year that the application is submitted.
• You agree with the Research Integrity Clause.

Sponsor Institute/Organizations: Research Foundation – Flanders (FWO)

Sponsor Type:

Address: HOEK 38 Leuvenseweg 38, 1000 Brussel

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.